Larimar Therapeutics Ownership | Who Owns Larimar Therapeutics?


OverviewForecastFinancialsChart

Larimar Therapeutics Ownership Summary


Larimar Therapeutics is owned by 121.95% institutional investors, 1.45% insiders. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 39.65% of LRMR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.10% of its assets in Larimar Therapeutics shares.

LRMR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLarimar Therapeutics121.95%1.45%-23.40%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deerfield management company, l.p. (series c)21.23M39.65%$153.93M
Ra capital management6.05M11.29%$43.83M
Janus henderson group4.38M8.17%$31.63M
Goldman sachs group4.33M8.09%$31.41M
Blue owl capital lp3.86M7.21%$27.98M
Blackrock3.13M5.85%$22.72M
Vanguard group2.54M4.74%$18.40M
Verition fund management1.59M2.98%$11.56M
Adage capital partners gp1.37M2.56%$9.94M
Driehaus capital management1.31M2.45%$9.53M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue owl capital lp3.86M7.78%$27.98M
Deerfield management company, l.p. (series c)21.23M2.56%$153.93M
Dafna capital management639.97K1.11%$4.64M
Ra capital management6.05M0.58%$43.83M
Altium capital management lp196.00K0.58%$1.42M
Mangrove partners855.82K0.48%$6.20M
Ikarian capital323.53K0.41%$2.35M
Sphera funds management312.47K0.31%$2.27M
Atlas venture advisors172.18K0.27%$1.25M
Artia global partners lp90.49K0.13%$656.05K

Top Buyers

HolderShares% AssetsChange
Goldman sachs group4.33M0.01%915.20K
Blackrock3.13M0.00%795.19K
Fmr525.72K0.00%525.00K
Invesco441.29K0.00%429.47K
Janus henderson group4.38M0.02%356.42K

Top Sellers

HolderShares% AssetsChange
Stempoint capital lp---704.35K
Logos global management lp---700.00K
Rtw investments, lp---650.00K
Renaissance278.34K0.00%-225.10K
Ghost tree capital---210.60K

New Positions

HolderShares% AssetsChangeValue
Sphera funds management312.47K0.31%312.47K$2.27M
Altium capital management lp196.00K0.58%196.00K$1.42M
Wellington management group llp41.68K0.00%41.68K$302.20K
Alliancebernstein27.79K0.00%27.79K$201.48K
Corebridge financial22.63K0.00%22.63K$164.08K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-5.00
Ica group wealth management-75.00
Comerica bank-415.00
Metropolitan life insurance co/ny-1.41K
Group one trading-8.64K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024110-1.79%65,308,4722.69%1210.58%62-17.33%3454.55%
Mar 31, 202411251.35%63,594,67361.18%1441.79%75150.00%22-15.38%
Dec 31, 20237410.45%39,456,5091.83%891.15%3015.38%268.33%
Sep 30, 202367-38,745,794-0.72%881.12%26-33.33%2484.62%
Jun 30, 202367-2.90%39,027,6921.47%881.16%39-17.02%138.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.34M2.10%-
iShares Russell 2000 ETF1.10M1.72%-2.46K
Fidelity Advisor Biotechnology I524.80K0.82%-
Vanguard Institutional Extnd Mkt Idx Tr510.24K0.80%-352.30K
Fidelity Small Cap Index431.07K0.68%-11.27K
Invesco Dorsey Wright SmallCap Momt ETF422.53K0.66%-
Janus Henderson Hrzn Biotec E2 USD411.08K0.64%-20.44K
Alger Small Cap Growth B398.96K0.63%-
Heptagon Driehaus US Micro Cap Eq C$ Acc392.25K0.61%3.19K
iShares Russell 2000 Growth ETF372.43K0.58%-

Recent Insider Transactions


DateNameRoleActivityValue
Feb 16, 2024Hamilton Thomas Edward-Buy$500.00K
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M
Feb 16, 2024Flynn James E * Director by DeputizationBuy$12.50M
Feb 14, 2024THOMAS FRANK E-Buy$22.00K

Insider Transactions Trends


DateBuySell
2024 Q2--
2024 Q15-
2023 Q41-
2023 Q3--
2023 Q23-

LRMR Ownership FAQ


Who Owns Larimar Therapeutics?

Larimar Therapeutics shareholders are primarily institutional investors at 121.95%, followed by 1.45% insiders and -23.40% retail investors. The average institutional ownership in Larimar Therapeutics's industry, Biotech Stocks , is 44.97%, which Larimar Therapeutics exceeds.

Who owns the most shares of Larimar Therapeutics?

Larimar Therapeutics’s largest shareholders are Deerfield management company, l.p. (series c) (21.23M shares, 39.65%), Ra capital management (6.05M shares, 11.29%), and Janus henderson group (4.38M shares, 8.17%). Together, they hold 59.11% of Larimar Therapeutics’s total shares outstanding.

Does Blackrock own Larimar Therapeutics?

Yes, BlackRock owns 5.85% of Larimar Therapeutics, totaling 3.13M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 795.19K shares, a 34.00% change.

Who is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested?

Blue owl capital lp is Larimar Therapeutics’s biggest shareholder by percentage of total assets invested, with 7.78% of its assets in 3.86M Larimar Therapeutics shares, valued at 27.98M$.

Who is the top mutual fund holder of Larimar Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Larimar Therapeutics shares, with 2.10% of its total shares outstanding invested in 1.34M Larimar Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools